Држава: Малта
Језик: Енглески
Извор: Malta Medicines Authority
LORATADINE
Bayer PLC
R06AX13
LORATADINE
TABLET
LORATADINE 10 mg
OTC
ANTIHISTAMINES FOR SYSTEMIC USE
Authorised
2006-12-15
1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Clarityn Allergy 10mg Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION _ _ Each tablet contains 10 mg loratadine. Excipients with known effect: The quantity of lactose monohydrate in the loratadine 10 mg tablet composition is 71.3 mg. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet. White, to off-white, oval tablet with flask and bowl, score and “10” on one side, plain on the other side. The score line of the tablet is only to facilitate breaking for ease of swallowing and not to divide into equal doses. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Clarityn Allergy Tablets are indicated for the symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children over the age of 2 years with a body weight more than 30 kg_. _ 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Adults and children over 12 years of age: 10 mg once daily (one tablet once daily). _ _ _ _ _Paediatric population _ Children 2 to 12 years of age are dosed by weight: Body weight more than 30 kg: 10 mg once daily (one tablet once daily). Body weight 30 kg or less: The 10 mg strength tablet is not appropriate in children with a body weight less than 30 kg. There are other formulations more suitable for children 2 to 12 years old with body weight 30 kg or less. The safety and efficacy of Clarityn Allergy Tablets in children under 2 years of age have not been established. No data are available. _Patients with hepatic impairment _ Patients with severe liver impairment should be administered a lower initial dose because they may have reduced clearance of loratadine. An initial dose of 10 mg every other day Прочитајте комплетан документ